Rights and permissions
About this article
Cite this article
CABG could be least costly option for CAD in Japan. Pharmacoecon. Outcomes News 598, 4 (2010). https://doi.org/10.2165/00151234-201005980-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201005980-00007